These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 22895613)

  • 21. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
    Patel SJ; Duhart BT; Krauss AG; Moore LW; Egidi MF; Amiri HS; Gaber LW; Gaber AO
    Transplantation; 2008 Jul; 86(2):313-20. PubMed ID: 18645496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-year results of a prospective, randomized, single-center study of alemtuzumab compared with rabbit antithymocyte globulin induction in simultaneous kidney-pancreas transplantation.
    Stratta RJ; Rogers J; Orlando G; Farooq U; Al-Shraideh Y; Farney AC
    Transplant Proc; 2014; 46(6):1928-31. PubMed ID: 25131073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose RATG with or without basiliximab in renal transplantation: a matched-cohort observational study.
    Gentile G; Somma C; Gennarini A; Mastroluca D; Rota G; Lacanna F; Locatelli B; Remuzzi G; Ruggenenti P
    Am J Nephrol; 2015; 41(1):16-27. PubMed ID: 25612603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation.
    Flaman F; Zieroth S; Rao V; Ross H; Delgado DH
    J Heart Lung Transplant; 2006 Nov; 25(11):1358-62. PubMed ID: 17097501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporine prolongs delayed graft function in kidney transplantation: are rabbit anti-human thymocyte globulins the answer?
    Cravedi P; Codreanu I; Satta A; Turturro M; Sghirlanzoni M; Remuzzi G; Ruggenenti P
    Nephron Clin Pract; 2005; 101(2):c65-71. PubMed ID: 15942253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients.
    Tector AJ; Fridell JA; Mangus RS; Shah A; Milgrom M; Kwo P; Chalasani N; Yoo H; Rouch D; Liangpunsakul S; Herring S; Lumeng L
    Liver Transpl; 2004 Mar; 10(3):404-7. PubMed ID: 15004768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined induction therapy with rabbit antithymocyte globulin and rituximab in highly sensitized renal recipients.
    Laftavi MR; Pankewycz O; Feng L; Said M; Patel S
    Immunol Invest; 2015; 44(4):373-84. PubMed ID: 25942348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Rabbit Antithymocyte Globulin Dose on Long-term Outcomes in Heart Transplant Patients.
    Aliabadi AZ; Grömmer M; Dunkler D; Eskandary F; Salameh O; Gökler J; Hutschala D; Steinlechner B; Opfermann P; Laufer G; Zuckermann AO
    Transplantation; 2016 Mar; 100(3):685-93. PubMed ID: 26457604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction therapy by anti-thymocyte globulin (rabbit) versus basiliximab in deceased donor renal transplants and the effect on delayed graft function and outcomes.
    Foster CE; Weng RR; Piper M; Laugenou K; Ichii H; Lakey J; Malinoski D
    Transplant Proc; 2012 Jan; 44(1):164-6. PubMed ID: 22310605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New law of renal transplantation in Portugal associated with more acute rejection episodes and higher costs.
    Gonçalves JA; Jorge C; Atalaia A; Matias P; Bruges M; Birne R; Dickson J; Weigert A; Machado D
    Transplant Proc; 2012 Oct; 44(8):2276-9. PubMed ID: 23026572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deep vein thrombosis during rabbit antithymocyte globulin administration.
    Mathis AS; Rao V
    Transplant Proc; 2004 Dec; 36(10):3250-1. PubMed ID: 15686740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and economic analysis of short-course versus standard-course antithymocyte globulin (rabbit) induction therapy in deceased-donor renal transplant recipients.
    Marfo K; Akalin E; Wang C; Lu A
    Am J Health Syst Pharm; 2011 Dec; 68(23):2276-82. PubMed ID: 22095818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retreatment by antithymocyte globulin for second kidney transplantation: efficacy, tolerance and safety.
    Rodríguez-Reimundes E; Buron F; Chauvet C; Daoud S; Thaunat O; Brunet M; Badet L; Morelon E
    Transpl Immunol; 2013 Jan; 28(1):6-8. PubMed ID: 23220146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up.
    Mangus RS; Fridell JA; Vianna RM; Kwo PY; Chen J; Tector AJ
    Liver Transpl; 2012 Jul; 18(7):786-95. PubMed ID: 22237953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rabbit antithymocyte globulin as induction immunotherapy for pediatric deceased donor kidney transplantation.
    Kamel MH; Mohan P; Little DM; Awan A; Hickey DP
    J Urol; 2005 Aug; 174(2):703-7. PubMed ID: 16006954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of alemtuzumab vs. antithymocyte globulin induction therapy in primary non-sensitized renal transplant patients treated with rapid steroid withdrawal.
    Saull HE; Enderby CY; Gonwa TA; Wadei HM
    Clin Transplant; 2015 Jul; 29(7):573-80. PubMed ID: 25711849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection.
    Deeks ED; Keating GM
    Drugs; 2009 Jul; 69(11):1483-512. PubMed ID: 19634926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rabbit antithymocyte globulin induction therapy in adult renal transplantation.
    Hardinger KL
    Pharmacotherapy; 2006 Dec; 26(12):1771-83. PubMed ID: 17125438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of terminal complement blockade on the efficacy of induction with polyclonal rabbit antithymocyte globulin in living donor renal allografts.
    Goh BK; Chedid MF; Gloor JM; Raghavaiah S; Stegall MD
    Transpl Immunol; 2012 Oct; 27(2-3):95-100. PubMed ID: 22813834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participants.
    Lentine KL; Schnitzler MA; Xiao H; Brennan DC
    Trials; 2015 Aug; 16():365. PubMed ID: 26285695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.